Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital

Pregnancy Anemia Clinical Trial

— ANEMIA  

Official title:

Statement of Care of Anemia in Delivering Patients at Nord Franche-Comte Hospital

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04812821
• Other study ID #: 2019-02
• Status: Completed
• Start date: April 12, 2021
• Est. completion date: March 15, 2022

Study information

• Verified date: March 2021
• Source: Hopital Nord Franche-Comte
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

Anemia is a common pregnancy condition that has multiple origins. Its frequency and severity seem to be increasing, despite the existing management recommendations and the awareness of health professionals. The objective of this study is to make a statement of this pathology within our establishment, to evaluate the proportion of patients presenting this pathology and to highlight possible risk factors.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1177
• Est. completion date: March 15, 2022
• Est. primary completion date: October 12, 2021
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• > 18 years
• Delivery at Nord Franche-Comte Hospital
• Delivery = 32 weeks of amenorrhea
• Informed patient and non-opposition of participation

Exclusion Criteria:

• Protected adults (Patients under guardianship, curatorship, safeguard of justice or under family authorization)
• Medical interruption of pregnancy
• Patients with fetal death in utero or neonatal death
• Minor patients
• Premature delivery before 32 weeks

Related Conditions & MeSH terms

• Anemia
• Pregnancy Anemia

Intervention

Other:
• questionnaire
questionnaire post delivery

Locations

Country	Name	City	State
France	Hôpital Nord Franche-Comté	Trévenans

Sponsors (1)

Lead Sponsor	Collaborator
Hopital Nord Franche-Comte

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Estimation of the proportion of patients presenting anemia during delivery	Percentage of patients with hemoglobin less than 10.5 g/dl at entry into the delivery room	6 month
Secondary	Risk factors underlying anemia during delivery with a large questionnaire	Link between presence or absence of anemia and type of follow-up (gynecological or midwife, anemia during pregnancy and iron supplementation strategy and compliance), living conditions (geographical origin, socioeconomic situation, diet) and comorbidities	6 month